Dabigatran Treatment Following Transient Ischemic Attack and Minor Stroke

Trial Profile

Dabigatran Treatment Following Transient Ischemic Attack and Minor Stroke

Completed
Phase of Trial: Phase I/II

Latest Information Update: 29 Oct 2014

At a glance

  • Drugs Dabigatran etexilate (Primary)
  • Indications Embolism and thrombosis; Stroke; Transient ischaemic attacks
  • Focus Adverse reactions; Therapeutic Use
  • Acronyms DATAS
  • Most Recent Events

    • 29 Jan 2013 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top